LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lidocaine Hydrochloride And Epinephrine, and when can generic versions of Lidocaine Hydrochloride And Epinephrine launch?
Lidocaine Hydrochloride And Epinephrine is a drug marketed by B Braun Medical Inc, Belmora Llc, Eastman Kodak, Hospira, West-ward Pharms Int, and Empi. and is included in fourteen NDAs.
The generic ingredient in LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE?
- What are the global sales for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE?
- What is Average Wholesale Price for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE?
Summary for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
US Patents: | 0 |
Applicants: | 6 |
NDAs: | 14 |
Finished Product Suppliers / Packagers: | 5 |
Clinical Trials: | 228 |
DailyMed Link: | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE at DailyMed |
Recent Clinical Trials for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Montefiore Medical Center | N/A |
Jessyka Lighthall | Phase 3 |
Assiut University | N/A |
See all LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE clinical trials
Pharmacology for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
Drug Class | Amide Local Anesthetic Antiarrhythmic Catecholamine alpha-Adrenergic Agonist beta-Adrenergic Agonist |
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
Physiological Effect | Local Anesthesia |